{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T10:28:10Z","timestamp":1787308090704,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cgh.2026.01.026","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:52:15Z","timestamp":1770047535000},"page":"2465-2473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Early Treatment Initiation Optimizes Virologic and Liver Outcomes in Pediatric Patients With Chronic Hepatitis B Aged 0 to 18 Years"],"prefix":"10.1016","volume":"24","author":[{"given":"Lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bokang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqi","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4345-2149","authenticated-orcid":false,"given":"Jingmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.01.026_bib1","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1097\/CM9.0000000000001791","article-title":"Elimination of hepatitis B virus infection in children: experience and challenge in China","volume":"134","author":"Tang","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.cgh.2026.01.026_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41591-023-02782-x","article-title":"Real-world implementation of a multilevel interventions program to prevent mother-to-child transmission of HBV in China","volume":"30","author":"Yin","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.cgh.2026.01.026_bib3","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cgh.2026.01.026_bib4","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/HEP.0000000000000431","article-title":"Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference","volume":"78","author":"Ghany","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.01.026_bib5","first-page":"1309","article-title":"Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)","volume":"30","year":"2022","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.cgh.2026.01.026_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.01.026_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.14218\/JCTH.2021.00142","article-title":"Clinical predictors of functional cure in children 1-6 years-old with chronic hepatitis B","volume":"10","author":"Pan","year":"2022","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.cgh.2026.01.026_bib8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jhep.2019.06.009","article-title":"Early initiation of antiviral therapy contributes to a rapid and significant loss of serum HBsAg in infantile-onset hepatitis B","volume":"71","author":"Zhu","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.01.026_bib9","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/hep.30050","article-title":"Efficacy and safety of peginterferon Alfa-2a (40KD) in children with chronic hepatitis B: the PEG-B-ACTIVE study","volume":"68","author":"Wirth","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.01.026_bib10","first-page":"435","article-title":"[Research progress on clinical antiviral treatment of chronic hepatitis B in children]","volume":"32","year":"2024","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.cgh.2026.01.026_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/14787210.2021.1845652","article-title":"Spontaneous loss of chronic HBV infection markers in treatment-na\u00efve children: a systematic review and pooled meta-analyses","volume":"19","author":"Yang","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cgh.2026.01.026_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12985-021-01707-9","article-title":"The dynamic changes of HBV quasispecies diversity in infancy after immunoprophylaxis failure: a prospective cohort study","volume":"18","author":"Li","year":"2021","journal-title":"Virol J"},{"key":"10.1016\/j.cgh.2026.01.026_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12072-023-10597-8","article-title":"Why is the functional cure rate of young children with chronic hepatitis B receiving antiviral therapy considerably high?","volume":"18","author":"Wang","year":"2024","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2026.01.026_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jvh.12997","article-title":"Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up","volume":"26","author":"van Campenhout","year":"2019","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cgh.2026.01.026_bib15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2147\/IDR.S195144","article-title":"Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B","volume":"12","author":"Zheng","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.cgh.2026.01.026_bib16","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/infdis\/jix024","article-title":"Pegylated interferon alfa-2b add-on treatment in hepatitis B virus envelope antigen-positive chronic hepatitis B patients treated with nucleos(t)ide analogue: a randomized, controlled trial (PEGON)","volume":"215","author":"Chi","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cgh.2026.01.026_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S2468-1253(16)30189-3","volume":"2","author":"Bourli\u00e8re","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.01.026_bib18","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.2147\/IDR.S175707","article-title":"Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patients","volume":"11","author":"Yan","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2026.01.026_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/jvh.13154","article-title":"Long-term efficacy and safety of peginterferon in the treatment of children with HBeAg-positive chronic hepatitis B","volume":"26","author":"Liu","year":"2019","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cgh.2026.01.026_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12072-023-10631-9","article-title":"Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B","volume":"18","author":"Zhang","year":"2024","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2026.01.026_bib21","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/apt.17667","article-title":"Age at treatment initiation predicts response in children with chronic hepatitis B","volume":"58","author":"Wu","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.01.026_bib22","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/jvh.13598","article-title":"Long-term benefits of interferon-\u03b1 therapy in children with HBeAg-positive immune-active chronic hepatitis B","volume":"28","author":"Wang","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cgh.2026.01.026_bib23","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1440-1746.2009.05779.x","article-title":"Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B","volume":"24","author":"Wong","year":"2009","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526000546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526000546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T10:03:22Z","timestamp":1787306602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526000546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1542356526000546"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.01.026","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Treatment Initiation Optimizes Virologic and Liver Outcomes in Pediatric Patients With Chronic Hepatitis B Aged 0 to 18 Years","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Gastroenterological Association Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}